C Melguizo Selected Research

1- ((3- (3- chloro- 2- hydroxyproxy)- 1- methoxy)propyl)- 5- fluorouracil

9/2000

Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Melguizo Research Topics

Disease

7	Neoplasms (Cancer) 05/2022 - 09/2000
2	Colonic Neoplasms (Colon Cancer) 05/2022 - 10/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 10/2013
2	Drug-Related Side Effects and Adverse Reactions 10/2013 - 09/2005
1	Polyps 05/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2013
1	Stroke (Strokes) 01/2013
1	Myocardial Infarction 01/2013
1	Melanoma (Melanoma, Malignant) 08/2008
1	Embryonal Rhabdomyosarcoma 01/2006
1	Breast Neoplasms (Breast Cancer) 07/2003
1	Rhabdomyosarcoma 09/2000

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 10/2013 - 01/2003
1	Ethanol (Ethyl Alcohol)IBA 05/2022
1	Dextran SulfateIBA 05/2022
1	AzoxymethaneIBA 05/2022
1	Caspase 3 (Caspase-3)IBA 05/2022
1	CarcinogensIBA 01/2015
1	LigandsIBA 10/2013
1	Excipients (Suspending Agents)IBA 10/2013
1	Cytotoxins (Cytolysins)IBA 01/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2008
1	Hyaluronan ReceptorsIBA 08/2008
1	ProdrugsIBA 09/2005
1	AntigensIBA 01/2003
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2003
1	Glycoproteins (Glycoprotein)IBA 01/2003
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2003
1	pyrimidineIBA 09/2000
1	1- ((3- (3- chloro- 2- hydroxyproxy)- 1- methoxy)propyl)- 5- fluorouracilIBA 09/2000
1	Fluorouracil (Carac)FDA LinkGeneric 09/2000

Therapy/Procedure

6	Therapeutics 10/2013 - 09/2000
2	Drug Therapy (Chemotherapy) 10/2013 - 01/2006
1	Transplantation 01/2013
1	Immunotherapy 01/2003
1	Combination Drug Therapy (Combination Chemotherapy) 01/2003
1	Aftercare (After-Treatment) 09/2000